1)日本循環器学会:感染性心内膜炎の予防と治療に関するガイドライン(2017年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2017_nakatani_h.pdf (2020年2月閲覧)
2)Li JS, et al:Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633-638, 2000
3)Chirillo F, et al:Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol 112:1171-1176, 2013
4)Baddour LM, et al:Infective endocarditis in adults:Diagnosis, antimicrobial therapy, and management of complications;A scientific statement for healthcare professionals from the American Heart Association. Circulation 132:1435-1486, 2015
5)Holland LT, et al:Endocarditis and intravascular infections. Bennett EJ, et al(ed):Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, ninth edition, pp1068-1108e12, Elsevier, Philadelphia, 2019
6)Naito T, et al:Diagnostic workup for fever of unknown origin:A multicenter collaborative retrospective study. BMJ Open 20:3:e003971, 2013
7)Olaison L, et al:Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 157:885-892, 1997
8)Lederman MM, et al:Duration of fever during treatment of infective endocarditis. Medicine(Baltimore) 71:52-57, 1992
9)Habib G, et al;ESC Scientific Document Group:2015 ESC guidelines for the management of infective endocarditis:The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology(ESC). Endorsed by: European Association for Cardio-Thoracic Surgery(EACTS), the European Association of Nuclear Medicine(EANM). Eur Heart J 36:3075-3128, 2015